Context Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Context Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q2 2024.
  • Context Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 55M shares, a 244% increase year-over-year.
  • Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 16M shares, unchanged from 2022.
  • Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 16M shares, a 463% increase from 2021.
  • Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 2.83M shares, a 713% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 55M +39M +244% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 16M 0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 16M 0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 16M 0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 16M 0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 16M 0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 16M +13.1M +463% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 16M +15.6M +4322% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 16M +15.6M +4400% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 16M +15.6M +4472% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 2.83M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 361K +12.7K +3.64% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 355K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 349K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 348K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.